Board Change • May 20
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 8 experienced directors. No highly experienced directors. No independent directors (8 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Announcement • Mar 25
Kafr El Zayat For Pesticides & Chemicals Co.(S.A.E), Annual General Meeting, Apr 18, 2026 Kafr El Zayat For Pesticides & Chemicals Co.(S.A.E), Annual General Meeting, Apr 18, 2026, at 11:00 Egypt Standard Time. Location: cairo Egypt Announcement • Sep 04
Kafr El Zayat For Pesticides & Chemicals Co.(S.A.E) announces Annual dividend, payable on September 30, 2025 Kafr El Zayat For Pesticides & Chemicals Co.(S.A.E) announced Annual dividend of EGP 0.4500 per share payable on September 30, 2025, ex-date on September 28, 2025 and record date on September 29, 2025. Board Change • May 14
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 8 experienced directors. No highly experienced directors. No independent directors (8 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Announcement • Mar 20
Kafr El Zayat For Pesticides & Chemicals Co.(S.A.E), Annual General Meeting, Apr 26, 2025 Kafr El Zayat For Pesticides & Chemicals Co.(S.A.E), Annual General Meeting, Apr 26, 2025, at 08:00 Egypt Standard Time. Location: cairo Egypt Valuation Update With 7 Day Price Move • Sep 09
Investor sentiment improves as stock rises 36% After last week's 36% share price gain to ج.م11.66, the stock trades at a trailing P/E ratio of 8.1x. Average trailing P/E is 8x in the Chemicals industry in Egypt. Total returns to shareholders of 597% over the past three years. Valuation Update With 7 Day Price Move • Aug 25
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to ج.م8.62, the stock trades at a trailing P/E ratio of 6x. Average trailing P/E is 8x in the Chemicals industry in Egypt. Total returns to shareholders of 357% over the past three years. New Risk • Aug 17
New major risk - Earnings quality The company has a high level of non-cash earnings. Accrual ratio: 43% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (43% accrual ratio). Minor Risks Paying a dividend despite having no free cash flows. Market cap is less than US$100m (ج.م1.30b market cap, or US$26.7m). Reported Earnings • Aug 17
Second quarter 2024 earnings released: EPS: ج.م0.56 (vs ج.م0.23 in 2Q 2023) Second quarter 2024 results: EPS: ج.م0.56 (up from ج.م0.23 in 2Q 2023). Revenue: ج.م724.5m (up 34% from 2Q 2023). Net income: ج.م101.2m (up 144% from 2Q 2023). Profit margin: 14% (up from 7.6% in 2Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has only increased by 24% per year, which means it is significantly lagging earnings growth. Reported Earnings • May 19
First quarter 2024 earnings released: EPS: ج.م0.71 (vs ج.م0.84 in 1Q 2023) First quarter 2024 results: EPS: ج.م0.71. Revenue: ج.م791.2m (up 77% from 1Q 2023). Net income: ج.م128.0m (up 28% from 1Q 2023). Profit margin: 16% (down from 22% in 1Q 2023). The decrease in margin was driven by higher expenses. Upcoming Dividend • Mar 27
Upcoming dividend of ج.م0.60 per share Eligible shareholders must have bought the stock before 03 April 2024. Payment date: 07 April 2024. Payout ratio is a comfortable 63% but the company is paying out more than the cash it is generating. Trailing yield: 7.3%. Within top quartile of Egyptian dividend payers (6.3%). Higher than average of industry peers (4.9%). Reported Earnings • Feb 17
Full year 2023 earnings released: EPS: ج.م0.95 (vs ج.م0.95 in FY 2022) Full year 2023 results: EPS: ج.م0.95 (up from ج.م0.95 in FY 2022). Revenue: ج.م2.30b (up 47% from FY 2022). Net income: ج.م171.8m (up 51% from FY 2022). Profit margin: 7.5% (up from 7.3% in FY 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has only increased by 37% per year, which means it is significantly lagging earnings growth. New Risk • Jan 21
New major risk - Financial data availability The company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risks No financial data reported. High level of non-cash earnings (36% accrual ratio). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Shareholders have been diluted in the past year (49% increase in shares outstanding). Market cap is less than US$100m (ج.م1.59b market cap, or US$51.5m). Reported Earnings • Nov 18
Third quarter 2022 earnings released: ج.م0.03 loss per share (vs ج.م0.055 profit in 3Q 2021) Third quarter 2022 results: ج.م0.03 loss per share (down from ج.م0.055 profit in 3Q 2021). Revenue: ج.م224.0m (up 32% from 3Q 2021). Net loss: ج.م3.71m (down 157% from profit in 3Q 2021). New Risk • Oct 11
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Egyptian stocks, typically moving 6.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (36% accrual ratio). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (6.1% average weekly change). Shareholders have been diluted in the past year (49% increase in shares outstanding). Market cap is less than US$100m (ج.م1.38b market cap, or US$44.8m). Valuation Update With 7 Day Price Move • Oct 01
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ج.م8.35, the stock trades at a trailing P/E ratio of 16.7x. Average trailing P/E is 12x in the Chemicals industry in Egypt. Total returns to shareholders of 814% over the past three years. New Risk • Jun 30
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 49% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (36% accrual ratio). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Shareholders have been diluted in the past year (49% increase in shares outstanding). Market cap is less than US$100m (ج.م1.05b market cap, or US$34.1m). Upcoming Dividend • Apr 11
Upcoming dividend of ج.م0.63 per share at 9.6% yield Eligible shareholders must have bought the stock before 18 April 2023. Payment date: 20 April 2023. Payout ratio is a comfortable 53% but the company is not cash flow positive. Trailing yield: 9.6%. Within top quartile of Egyptian dividend payers (8.0%). Higher than average of industry peers (6.1%). Valuation Update With 7 Day Price Move • Feb 28
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to ج.م6.44, the stock trades at a trailing P/E ratio of 6.4x. Average trailing P/E is 7x in the Chemicals industry in Egypt. Total returns to shareholders of 329% over the past three years. Reported Earnings • Feb 23
Full year 2022 earnings released: EPS: ج.م8.99 (vs ج.م0.54 in FY 2021) Full year 2022 results: EPS: ج.م8.99 (up from ج.م0.54 in FY 2021). Revenue: ج.م1.06b (up 29% from FY 2021). Net income: ج.م121.1m (up 89% from FY 2021). Profit margin: 12% (up from 7.9% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 145% per year but the company’s share price has only increased by 53% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Jan 17
Investor sentiment improved over the past week After last week's 28% share price gain to ج.م75.75, the stock trades at a trailing P/E ratio of 10.1x. Average trailing P/E is 9x in the Chemicals industry in Egypt. Total returns to shareholders of 394% over the past three years. Valuation Update With 7 Day Price Move • Dec 29
Investor sentiment improved over the past week After last week's 16% share price gain to ج.م58.75, the stock trades at a trailing P/E ratio of 7.9x. Average trailing P/E is 8x in the Chemicals industry in Egypt. Total returns to shareholders of 276% over the past three years. Valuation Update With 7 Day Price Move • Dec 04
Investor sentiment improved over the past week After last week's 16% share price gain to ج.م48.80, the stock trades at a trailing P/E ratio of 6.5x. Average trailing P/E is 7x in the Chemicals industry in Egypt. Total returns to shareholders of 178% over the past three years. Board Change • Nov 16
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 11 experienced directors. No highly experienced directors. 1 independent director (10 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Valuation Update With 7 Day Price Move • Oct 16
Investor sentiment improved over the past week After last week's 20% share price gain to ج.م37.32, the stock trades at a trailing P/E ratio of 5x. Average trailing P/E is 5x in the Chemicals industry in Egypt. Total returns to shareholders of 112% over the past three years. Reported Earnings • May 20
First quarter 2022 earnings released: EPS: ج.م3.32 (vs ج.م2.77 in 1Q 2021) First quarter 2022 results: EPS: ج.م3.32 (up from ج.م2.77 in 1Q 2021). Revenue: ج.م268.2m (up 18% from 1Q 2021). Net income: ج.م39.8m (up 20% from 1Q 2021). Profit margin: 15% (in line with 1Q 2021). Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth. Board Change • Apr 27
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 11 experienced directors. No highly experienced directors. 1 independent director (10 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Upcoming Dividend • Apr 14
Upcoming dividend of ج.م4.00 per share Eligible shareholders must have bought the stock before 21 April 2022. Payment date: 27 April 2022. The company last paid an ordinary dividend in May 2014. The average dividend yield among industry peers is 4.6%. Valuation Update With 7 Day Price Move • May 10
Investor sentiment improved over the past week After last week's 21% share price gain to ج.م30.91, the stock trades at a trailing P/E ratio of 17.1x. Average trailing P/E is 11x in the Chemicals industry in Egypt. Total returns to shareholders of 29% over the past three years. Upcoming Dividend • Apr 18
Inaugural dividend of ج.م2.50 per share Eligible shareholders must have bought the stock before 25 April 2021. Payment date: 27 April 2021. The company last paid an ordinary dividend in April 2018. The average dividend yield among industry peers is 5.9%. Valuation Update With 7 Day Price Move • Mar 16
Investor sentiment deteriorated over the past week After last week's 16% share price decline to ج.م29.99, the stock trades at a trailing P/E ratio of 16.6x, down from the previous P/E ratio of 19.7x. Average P/E is 12x in the Chemicals industry in Egypt. Total returns to shareholders over the past three years are 5.3%. Reported Earnings • Mar 06
Full year 2020 earnings released The company reported a solid full year result with improved earnings and revenues, although profit margins were weaker. Full year 2020 results: Revenue: ج.م740.0m (up 10% from FY 2019). Net income: ج.م27.3m (up 2.3% from FY 2019). Profit margin: 3.7% (down from 4.0% in FY 2019). Valuation Update With 7 Day Price Move • Feb 23
Investor sentiment improved over the past week After last week's 20% share price gain to ج.م40.50, the stock is trading at a trailing P/E ratio of 18.5x, up from the previous P/E ratio of 15.5x. This compares to an average P/E of 12x in the Chemicals industry in Egypt. Total returns to shareholders over the past three years are 35%. Is New 90 Day High Low • Feb 23
New 90-day high: ج.م40.50 The company is up 27% from its price of ج.م31.77 on 25 November 2020. The Egyptian market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 18% over the same period. Is New 90 Day High Low • Feb 03
New 90-day high: ج.م33.65 The company is up 45% from its price of ج.م23.19 on 05 November 2020. The Egyptian market is up 15% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 27% over the same period. Valuation Update With 7 Day Price Move • Feb 02
Investor sentiment improved over the past week After last week's 19% share price gain to ج.م31.91, the stock is trading at a trailing P/E ratio of 14.6x, up from the previous P/E ratio of 12.3x. This compares to an average P/E of 11x in the Chemicals industry in Egypt. Total returns to shareholders over the past three years are 2.0%. Valuation Update With 7 Day Price Move • Nov 23
Market bids up stock over the past week After last week's 28% share price gain to ج.م34.00, the stock is trading at a trailing P/E ratio of 11x, up from the previous P/E ratio of 8.6x. This compares to an average P/E of 9x in the Chemicals industry in Egypt. Total returns to shareholders over the past three years are 16%. Is New 90 Day High Low • Nov 14
New 90-day high: ج.م28.51 The company is up 9.0% from its price of ج.م26.20 on 16 August 2020. The Egyptian market is up 4.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 3.0% over the same period. Valuation Update With 7 Day Price Move • Nov 11
Market bids up stock over the past week After last week's 21% share price gain to ج.م28.01, the stock is trading at a trailing P/E ratio of 9x, up from the previous P/E ratio of 7.5x. This compares to an average P/E of 10x in the Chemicals industry in Egypt. Total return to shareholders over the past three years is a loss of 18%. Is New 90 Day High Low • Oct 22
New 90-day low: ج.م24.13 The company is down 1.0% from its price of ج.م24.32 on 22 July 2020. The Egyptian market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 12% over the same period.